The bioactivity results herein presented clearly show the increased biological potential of guanidino nucleosides relative to their azido counterparts, with compounds showing significant cytotoxicity to cancer cells, the ability to inhibit butyrylcholinesterase, and neuroprotective effects, among which are promising lead/hit molecules. This evidence concerns the gene BCHE and cancer.